In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney
Brigham and Women's Hospital, Division of Global Health Equity

Recent discussion topics

Proteus and MDR-TB

By Philip Lederer on 12 Oct, 2015 0 Replies

Could the Proteus digitized pills be used for the treatment of MDR/XDR-TB? thanks! best regards, Phil

Repurposing old drugs (meropenem and faropenem)

By Masoud Dara, MD on 07 Oct, 2015 4 Replies

Dear colleagues, On 6 October 2015, Horizon, the EU Magazine for Research and Innovation presented a short overview of ongoing work funded by EU on repurposing old drugs to fight TB. “The advantage of repurposing old drugs to fight new diseases is that…

Fwd: TAGline Fall 2015: In Defense of Stringency

By Erica Lessem on 07 Oct, 2015 0 Replies

Dear all, Below please find the most recent issue of tagline, which focuses on regulatory challenges and the importance of efficient but stringent regulatory agencies, in the US and globally, to ensure health and safety for people with TB, HIV, and other…

New community members

User Photo

Dr. Victor O. Ezike

Public health physician with focus on community health promotion and protection in Nigeria, USA and other countries covered by doctors without borders

Affiliated Organizations


Work Locations

Nigeria; United States

User Photo

Alan Adler

Affiliated Organizations

Doctors without Borders

Work Locations


User Photo

Nitish Beharee

Affiliated Organizations

Ministry of Health

Work Locations